Healthcare Resource Utilization in Adults Diagnosed With Acute Myeloid Leukemia (AML)
Condition(s):Acute Myeloid Leukemia (AML)Last Updated:November 8, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Acute Myeloid Leukemia (AML)Last Updated:November 8, 2022Completed
Condition(s):Acute Myeloid LeukemiaLast Updated:August 6, 2020Completed
Condition(s):Acute Myeloid Leukemia, AdultLast Updated:January 21, 2022Terminated
Condition(s):Acute Myeloid Leukemia; Acute Lymphoblastic LeukemiaLast Updated:December 22, 2015Terminated
Condition(s):AML/MDSLast Updated:January 6, 2023Active, not recruiting
Condition(s):Indolent Systemic MastocytosisLast Updated:January 19, 2015Unknown status
Condition(s):Acute Myeloid Leukemia (AML)Last Updated:August 21, 2023Completed
Condition(s):FMS-Like Tyrosine Kinase 3 (FLT3)-Mutated Acute Myeloid Leukemia; Acute Myeloid Leukemia; Aggressive Systemic Mastocytosis; Mast Cell Leukemia; Systemic Mastocytosis With an Associated Hematologic NeoplasmLast Updated:April 3, 2023Available
Condition(s):Acute Myeloid LeukemiaLast Updated:April 19, 2023Completed
Condition(s):Acute Myeloid Leukemia; Myelodysplastic Syndrome With Excess Blasts-2Last Updated:June 15, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.